Alzheimer’s disease is anything but rare and its toll on our population is reaching cataclysmic proportions. It’s estimated that if the course of the disease is not slowed or halted, the number of Americans affected will grow from five million to more than 16 million individuals by 2050. But things are not all doom and gloom! In this webinar, Dr. Sylvain Lesné discusses recent developments in Alzheimer’s disease research, including where we may be headed in the near and more-distant future.
